The Gross Margin of Vaxcell Bio Therapeutics (323990.KQ) is 19.21%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 19.21% |
2023-12-31 | 51.94% |